radiofree.asia

Pfizer’s full FDA approval could lead to even greater profits

Pfizer reported a blockbuster year in lobbying and revenue ahead of the Food and Drug Administration’s full approval announcement.

This post was originally published on Original Journalism from OpenSecrets News.